fda approval status bpc-157 2026 Big news for the peptide space., The Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to NBC News | The claims

BPC-157 is a peptide known for its gut-restorative, wound-healing, and neuroprotective properties

Poor BBB penetration, rapid systemic metabolism, and dose-limiting peripheral toxicity often necessitate high systemic doses, increasing the risk of adverse effects while yielding limited CNS efficacy (Passeri et al., 2022)

NAD+ supports mitochondria while Epithalon supports DNA and circadian regulation

Preclinical and in vitro studies suggest that Epithalon may influence telomere dynamics, oxidative stress responses, gene expression patterns, and tissue-specific cell functions

The Future of MOTS-C Research: What Is Coming The MOTS-c field is advancing rapidly, with several threads of research likely to reshape clinical dosing recommendations within the next five years